ImpediMed Ltd
ASX:IPD

Watchlist Manager
ImpediMed Ltd Logo
ImpediMed Ltd
ASX:IPD
Watchlist
Price: 0.04 AUD -3.61% Market Closed
Market Cap: 81m AUD

During the last 3 months ImpediMed Ltd insiders bought 57.4k AUD , and have not sold any shares. The stock price has dropped by 25% over this period (open performance analysis).

The last transaction was made on Mar 4, 2025 by Ms Christine Emmanuel-Donnelly (Company Secretary) , who bought 13.4k AUD worth of IPD shares.

Last Transactions:
Ms Christine Emmanuel-Donnelly
Company Secretary
AU$+20.7k
Ms Christine Emmanuel-Donnelly
Company Secretary
AU$+13.4k
Ms Christine Emmanuel-Donnelly
Company Secretary
AU$+14.9k
Mr Andrew John Grant
Non-Executive Director
AU$+8.4k
Ms Christine Emmanuel-Donnelly
Company Secretary
AU$+14.8k
Mr Andrew John Grant
Non-Executive Director
AU$+8.4k
Ms Christine Emmanuel-Donnelly
Company Secretary
AU$+15.9k
Mr Andrew John Grant
Non-Executive Director
AU$+28.8k
Ms Christine Emmanuel-Donnelly
Company Secretary
AU$+10k
Mr Andrew John Grant
Non-Executive Director
AU$+50k
Christine Emmanuel-Donnelly
Non-Executive Director
AU$+8k
Janelle Delaney
Chief Financial Officer
AU$+50.1k
Andrew Grant
CEO and Managing Director
AU$+8.1k
Ms Janelle Delaney
Senior Vice President & General Counsel
AU$+50k
Ms Janelle Delaney
Senior Vice President & General Counsel
AU$+50k
Ms Janelle Delaney
Senior Vice President & General Counsel
AU$+100.1k
Mr Andrew John Grant
Non-Executive Director
AU$+87k
Ms Christine Emmanuel-Donnelly
Company Secretary
AU$+10.1k
Mr Andrew John Grant
Non-Executive Director
AU$+10.9k
Janelle Delaney
Chief Financial Officer
AU$+134.7k
Christine Emmanuel-Donnelly
Non-Executive Director
AU$+9.5k
Christine Emmanuel-Donnelly
Non-Executive Director
AU$+10.5k
David Anderson
CEO
AU$+13.5k
Amit Patel
CEO and Managing Director
AU$+18.5k
Donald (Don) Williams
Non-Executive Director
AU$+29.7k
Janet West
Non-Executive Director
AU$+21.6k
David Anderson
CEO
AU$+144.4k
Donald (Don) Williams
Non-Executive Director
AU$+158k
Janet West
Non-Executive Director
AU$+46.5k
Donald (Don) Williams
Non-Executive Director
AU$+82.5k
Donald (Don) Williams
Non-Executive Director
AU$+17.5k
Richard Valencia
President and Chief Executive Officer
AU$+51.7k
View All Transactions

During the last 3 months ImpediMed Ltd insiders bought 57.4k AUD , and have not sold any shares. The stock price has dropped by 25% over this period (open performance analysis).

The last transaction was made on Mar 4, 2025 by Ms Christine Emmanuel-Donnelly (Company Secretary) , who bought 13.4k AUD worth of IPD shares.

Sold
0-3
months
0 AUD
0
3-6
months
0 AUD
0
6-9
months
0 AUD
0
9-12
months
0 AUD
0
Bought
0-3
months
2
57.4k AUD
3-6
months
2
39.1k AUD
6-9
months
2
88.8k AUD
9-12
months
3
66.2k AUD

ImpediMed Ltd
Insider Trading Chart

ImpediMed Ltd
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

ImpediMed Ltd
Last Insider Transactions

Global
Insiders Monitor

ImpediMed Ltd
Glance View

Market Cap
81m AUD
Industry
Health Care

ImpediMed Ltd. engages in the development and distribution of bioimpedance devices with a focus on medical applications in the fluid status area. The company is headquartered in Brisbane, Queensland and currently employs 73 full-time employees. The company went IPO on 2007-10-24. The firm develops various medical products that use bioimpedance spectroscopy (BIS) to measure and monitor fluid status and tissue composition. Its product includes SOZO Digital Health Platform. The company is a non-invasive BIS device delivers a snapshot of fluid status and tissue composition in approximately 30 seconds. The Company’s SOZO Applications offer clinicians deeper insights into a patient’s health. SOZO Applications include various software applications, such as L-Dex Analysis for Lymphedema, Body Composition Analysis, Segmental Analysis and HF-Dex Analysis for Heart Failure. The Company’s research devices include SFB7 and ImpediVET. SFB7 single channel, tetrapolar BIS device, which measures fluid status and tissue composition for clinical and research applications.

IPD Intrinsic Value
0.07 AUD
Undervaluation 40%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top